Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Pipeline Watch: Phase III Misses For Fovista, Istradefylline And Vonapanitase

Dec 16 2016

• By John Davis

Pipeline

Related Companies

Iveric Bio, Inc.

Astellas Pharma, Inc.

Pfizer Inc.

Kyowa Kirin Co., Ltd.

Proteon Therapeutics, Inc

Achaogen, Inc.

Synergy Pharmaceuticals, Inc.

Ironwood Pharmaceuticals, Inc.

BioMarin Pharmaceutical Inc.

Chugai Pharmaceutical Co., Ltd.

Atara Biotherapeutics, Inc.

Genticel S.A.

BioDelivery Sciences International, Inc.

Sio Gene Therapies, Inc.

Gossamer Bio, Inc.

Teijin Pharma Limited.

Centrexion Therapeutics Corporation

Phio Pharmaceuticals Corp.

aTyr Pharma, Inc.

Revance Therapeutics, Inc.

Pharnext SA

Celladon Corporation

Eisai Co., Ltd.

Merck & Co., Inc.

Orphazyme A/S

SELLAS Life Sciences Group, Inc.

MorphoSys AG

Sage Therapeutics, Inc.

Zealand Pharma A/S

Pfizer Inc.

CSL Limited

Eli Lilly and Company

Boehringer Ingelheim GmbH

Vericel Corporation

Ferring Pharmaceuticals

Roche Holding AG

Gilead Sciences, Inc.

Biogen, Inc.

AbbVie Inc.

Novartis AG

Genmab A/S

Intercept Pharmaceuticals, Inc.

Additional Topics

Approvals Research & Development Pipeline Watch BioPharmaceutical

More from New Products

More from Scrip

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window